Esomer L 75mg/40mg Capsule is a combination pharmaceutical formulation containing Levosulpiride 75mg and Esomeprazole 40mg, indicated for the management of gastrointestinal disorders characterized by acid-related symptoms and motility disturbances. Levosulpiride, a selective dopamine D2 receptor antagonist, facilitates gastrointestinal motility by enhancing gastric emptying and improving esophageal peristalsis, thereby alleviating symptoms such as dyspepsia, gastroesophageal reflux, and functional dyspepsia. Esomeprazole, a proton pump inhibitor (PPI), effectively suppresses gastric acid secretion by inhibiting the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells, providing symptomatic relief and promoting mucosal healing in conditions such as gastroesophageal reflux disease (GERD), erosive esophagitis, and peptic ulcer disease. The synergistic action of Levosulpiride and Esomeprazole in Esomer L Capsule offers comprehensive management by addressing both acid suppression and motility enhancement. It is generally well tolerated; however, patients should be monitored for potential adverse effects including headache, dizziness, gastrointestinal disturbances, and extrapyramidal symptoms. Esomer L should be used under medical supervision, with dosage adjustments based on clinical response and patient tolerance. This combination therapy is particularly beneficial in patients exhibiting overlapping symptoms of acid reflux and delayed gastric emptying.